- The 8 States Most Likely to Legalize Marijuana Next
- Dow 18,000: Why This Market Rally May Never Happen Again
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
- BlackBerry Classic Review: A Bold Update for CrackBerry Fans
Investors are enthusiastic, but just like the yoga pants, Lululemon's stock is still too expensive.
Men and women are shopping more for comfortable shoes than dress shoes. These best selling and most wished for lists prove this trend.
Nike, Foot Locker and Skechers are just some companies cheering that more workers like the idea of wearing sneakers at the office.
The U.S. government holds a patent on cannabinoids and has collected money for licensing the patent. It could eventually collect thousands of dollars in royalties.
Researchers complain the pot the government now supplies is of poor quality. The government contract is open for bidding, but growers say the hurdles are insurmountable.
Congress passed a measure to prohibit the DEA from using federal money to raid state legal medical marijuana businesses.
The SEC has temporarily suspended trading in six different marijuana stocks, angering their shareholders.
In a new survey by RateWatch, most homeowners are happy with their homes and have no desire to go house hunting. Even property virgins don't want to buy a home.
The SEC is warning investors about recent trading halts in five different marijuana stocks.
It may be illegal to traffic drugs between states, but that isn't stopping these cannabis companies from building a national brand.